These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 35078435)

  • 21. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
    Huang YT; Heist RS; Chirieac LR; Lin X; Skaug V; Zienolddiny S; Haugen A; Wu MC; Wang Z; Su L; Asomaning K; Christiani DC
    J Clin Oncol; 2009 Jun; 27(16):2660-7. PubMed ID: 19414679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
    Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
    BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian clock associates with tumor microenvironment in thoracic cancers.
    Yang Y; Yuan G; Xie H; Wei T; Zhu D; Cui J; Liu X; Shen R; Zhu Y; Yang X
    Aging (Albany NY); 2019 Dec; 11(24):11814-11828. PubMed ID: 31881010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
    Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of circadian clock genes as regulators of immune infiltration in Hepatocellular Carcinoma.
    Zhang Z; Liang Z; Gao W; Yu S; Hou Z; Li K; Zeng P
    J Cancer; 2022; 13(11):3199-3208. PubMed ID: 36118525
    [No Abstract]   [Full Text] [Related]  

  • 30. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
    Zhou M; Chen Y; Gu X; Wang C
    Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
    Ma Q; Geng K; Xiao P; Zeng L
    Biomed Res Int; 2021; 2021():5963868. PubMed ID: 34518802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose restriction induces AMPK-SIRT1-mediated circadian clock gene Per expression and delays NSCLC progression.
    Li B; Chen Q; Feng Y; Wei T; Zhong Y; Zhang Y; Feng Q
    Cancer Lett; 2023 Nov; 576():216424. PubMed ID: 37778683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
    Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Deleterious
    Zhang K; Hong X; Song Z; Xu Y; Li C; Wang G; Zhang Y; Zhao X; Zhao Z; Zhao J; Huang M; Huang D; Qi C; Gao C; Cai S; Gu F; Hu Y; Xu C; Wang W; Lou Z; Zhang Y; Liu L
    Clin Cancer Res; 2020 Jul; 26(14):3649-3661. PubMed ID: 32241817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer.
    Zhou Y; Fan Y; Mao Y; Lou M; Liu X; Yuan K; Tong J
    Biomark Med; 2022 May; 16(7):523-535. PubMed ID: 35199566
    [No Abstract]   [Full Text] [Related]  

  • 36. Disruptions of Circadian Genes in Cutaneous Melanoma-An In Silico Analysis of Transcriptome Databases.
    Lesicka M; Nedoszytko B; Reszka E
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of MYEOV reflects poor prognosis in non-small cell lung cancer.
    Zhang R; Ma A
    Gene; 2021 Feb; 770():145337. PubMed ID: 33278551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TIMELESS mutation alters phase responsiveness and causes advanced sleep phase.
    Kurien P; Hsu PK; Leon J; Wu D; McMahon T; Shi G; Xu Y; Lipzen A; Pennacchio LA; Jones CR; Fu YH; Ptáček LJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):12045-12053. PubMed ID: 31138685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.
    Neilsen BK; Frodyma DE; McCall JL; Fisher KW; Lewis RE
    PLoS One; 2019; 14(1):e0209224. PubMed ID: 30629587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.